Loading...

LexaGene Holdings Inc.

0V43.LLSE
Healthcare
Biotechnology
£0.16
£-0.07(-30.43%)

LexaGene Holdings Inc. (0V43.L) Stock Overview

Explore LexaGene Holdings Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.5/100

Key Financials

Market Cap20.7M
P/E Ratio-1.00
EPS (TTM)$-0.12
ROE-1.25%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

0V43.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LexaGene Holdings Inc. (0V43.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.00 and a market capitalization of 20.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;